Mark Paul has been appointed president of North American operations for CROS NT. Mr. Paul brings operational and commercial experience to his new role. Most recently he served as senior vice president of program management for the company.
 
Andrew MacGarvey, CROS NT chief executive officer, said ‘Mark is the perfect candidate for what is an important role within the business. He has a strong customer focus and a great understanding of the needs of our US customer base. We are investing heavily in the region and Mark will be charged with growing our capability and connecting our service portfolio with the needs of the market there. I look forward to working with him and his team as we continue to expand the business.’
  
Mr. Paul has more than 25 years of experience serving customers and managing clinical trials in a number of successful clinical development businesses including chief executive officer of StatWorks, Inc., co-founder and chief executive officer of PharPoint Research, managing partner, sales and marketing, Veracity Logic, LLC, and several management positions at Quintiles, Inc.